C07D 279/04
1,3-thiazines
Official title: 1,3-Thiazines; Hydrogenated 1,3-thiazines
C07D279/04 (1,3-thiazines) appears on 295 US grants and 174 published applications in this corpus.
Search patents in C07D- Granted patents
- 295
- Published applications
- 174
- Assignees
- 139
- Inventors
- 816
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 23 | 0 |
| 1978 | 7 | 0 |
| 1979 | 2 | 0 |
| 1980 | 7 | 0 |
| 1981 | 11 | 0 |
| 1982 | 2 | 0 |
| 1983 | 2 | 0 |
| 1984 | 5 | 0 |
| 1985 | 13 | 0 |
| 1986 | 6 | 0 |
| 1987 | 7 | 0 |
| 1988 | 6 | 0 |
| 1989 | 6 | 0 |
| 1990 | 4 | 0 |
| 1991 | 6 | 0 |
| 1992 | 7 | 0 |
| 1993 | 3 | 0 |
| 1994 | 2 | 0 |
| 1995 | 4 | 0 |
| 1996 | 8 | 0 |
| 1997 | 10 | 0 |
| 1998 | 10 | 0 |
| 1999 | 5 | 0 |
| 2000 | 10 | 0 |
| 2001 | 4 | 3 |
| 2002 | 9 | 5 |
| 2003 | 6 | 12 |
| 2004 | 6 | 8 |
| 2005 | 6 | 6 |
| 2006 | 1 | 11 |
| 2007 | 4 | 4 |
| 2008 | 5 | 3 |
| 2009 | 2 | 5 |
| 2010 | 6 | 9 |
| 2011 | 0 | 7 |
| 2012 | 8 | 13 |
| 2013 | 5 | 10 |
| 2014 | 12 | 9 |
| 2015 | 7 | 9 |
| 2016 | 6 | 9 |
| 2017 | 6 | 4 |
| 2018 | 8 | 8 |
| 2019 | 4 | 3 |
| 2020 | 4 | 7 |
| 2021 | 3 | 5 |
| 2022 | 2 | 9 |
| 2023 | 4 | 8 |
| 2024 | 0 | 2 |
| 2025 | 4 | 4 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compounds, compositions, and methods for isolation of nucleic acids30 Jun 2026US 12,668,577 B2Ptomega Corporation
- Nitrogen-containing heterocyclic compound having NRF2 activation effect14 Oct 2025US 12,441,735 B2Chugai Seiyaku Kabushiki Kaisha
- Ophthalmic devices2 Sep 2025US 12,405,488 B2Bausch + Lomb Ireland Limited
- Sulfur (VI) fluoride compounds and methods for the preparation thereof19 Aug 2025US 12,390,424 B2The Scripps Research Institute
- 2,3-diaryl-2,3-dihydro-4H-1,3-thiazin-4-one compounds and methods for making20 May 2025US 12,304,895 B2The Penn State Research Foundation University
- Haptens and antigens for detecting xylazine and methods for synthesizing the same13 Aug 2026US 2026/0234114 A1Qingdao Henderson Biological Technology Co., Ltd.
- 2,3-diaryl-2,3-dihydro-4h-1,3-thiazin-4-one compounds and methods for making23 Oct 2025US 2025/0326727 A1The Penn State Research Foundation
- Ophthalmic devices25 Sep 2025US 2025/0298263 A1Bausch + Lomb Ireland Limited
- Nitrogen-containing heterocyclic compound having nrf2 activation effect29 May 2025US 2025/0171457 A1Chugai Seiyaku Kabushiki Kaisha
- Nitrogen-containing heterocyclic compound having nrf2 activation effect13 Mar 2025US 2025/0084093 A1
Most cited
By later US patents
- Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof277US 5,549,974 AAffymax Technologies N.V. · 1996
- Photolabile compounds and methods for their use151US 5,739,386 AAffymax Technologies N.V. · 1998
- Medicaments for the treatment of disorders of lipometabolism and their use138US 4,405,644 ABayer Aktiengesellschaft · 1983
- Heterocyclic compounds114US 4,742,060 ANihon Tokushu Noyaku Seizo K. K. · 1988
- Amino acid derivatives100US 5,157,041 AHoffmann-La Roche Inc. · 1992